{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:05:39Z","timestamp":1794409539966,"version":"4.9.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","award":["JP22fk0108523"],"award-info":[{"award-number":["JP22fk0108523"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","award":["JP24mk0121280"],"award-info":[{"award-number":["JP24mk0121280"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","award":["JP233fa727001"],"award-info":[{"award-number":["JP233fa727001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","award":["JP21mk0101189"],"award-info":[{"award-number":["JP21mk0101189"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031417","name":"Scottish Prison Service","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031417","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008663","name":"Health and Environmental Sciences Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["24K02202"],"award-info":[{"award-number":["24K02202"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.vascn.2024.107530","type":"journal-article","created":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T07:59:21Z","timestamp":1719215961000},"page":"107530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Contractility assessment using aligned human iPSC-derived cardiomyocytes"],"prefix":"10.1016","volume":"128","author":[{"given":"Ayano","family":"Satsuka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre J.S.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kawagishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Yanagida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yoshinaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Kurokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunari","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vascn.2024.107530_bb0005","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/hep.27488","article-title":"Cardiac dysfunction associated with a nucleotide polymerase inhibitor for treatment of hepatitis C","volume":"62","author":"Ahmad","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.vascn.2024.107530_bb0010","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.vascn.2016.12.003","article-title":"A new paradigm for drug-induced torsadogenic risk assessment using human iPS cell-derived cardiomyocytes","volume":"84","author":"Ando","year":"2017","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2024.107530_bb0015","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1016\/j.celrep.2018.08.079","article-title":"International multisite study of human-induced pluripotent stem cell-derived cardiomyocytes for drug proarrhythmic potential assessment","volume":"24","author":"Blinova","year":"2018","journal-title":"Cell Reports"},{"key":"10.1016\/j.vascn.2024.107530_bb0020","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/toxsci\/kfw200","article-title":"Comprehensive translational assessment of human- induced pluripotent stem cell derived cardiomyocytes for evaluating drug-induced arrhythmias","volume":"155","author":"Blinova","year":"2017","journal-title":"Toxicological Sciences"},{"issue":"3","key":"10.1016\/j.vascn.2024.107530_bb0025","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1161\/01.RES.68.3.689","article-title":"Contribution of cAMP-phosphodiesterase inhibition and sensitization of the contractile proteins for calcium to the inotropic effect of pimobendan in the failing human myocardium","volume":"68","author":"Bohm","year":"1991","journal-title":"Circulation Research"},{"key":"10.1016\/j.vascn.2024.107530_bb0030","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1161\/CIRCRESAHA.121.318183","article-title":"Cardiac tissues from stem cells: New routes to maturation and cardiac regeneration","volume":"128","author":"Campostrini","year":"2021","journal-title":"Circulation Research"},{"issue":"34","key":"10.1016\/j.vascn.2024.107530_bb0035","doi-asserted-by":"crossref","first-page":"21923","DOI":"10.1021\/acsami.5b11671","article-title":"Nanotopography-induced structural anisotropy and sarcomere development in human cardiomyocytes derived from induced pluripotent stem cells","volume":"8","author":"Carson","year":"2016","journal-title":"ACS Applied Materials & Interfaces"},{"key":"10.1016\/j.vascn.2024.107530_bb0040","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/s41592-022-01591-3","article-title":"Challenges and opportunities for the next generation of cardiovascular tissue engineering","volume":"19","author":"Cho","year":"2022","journal-title":"Nature Methods"},{"key":"10.1016\/j.vascn.2024.107530_bb0045","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nrd4309","article-title":"Lessons learned from the fate of AstraZeneca\u2019s drug pipeline: A five-dimensional framework","volume":"13","author":"Cook","year":"2014","journal-title":"In Nature Reviews Drug Discovery"},{"key":"10.1016\/j.vascn.2024.107530_bb0050","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5153625","article-title":"Mitochondrial maturation in human pluripotent stem cell derived cardiomyocytes","volume":"2017","author":"Dai","year":"2017","journal-title":"Stem Cells International"},{"key":"10.1016\/j.vascn.2024.107530_bb0055","author":"FDA"},{"issue":"3","key":"10.1016\/j.vascn.2024.107530_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107925","article-title":"Metabolic maturation media improve physiological function of human iPSC-derived cardiomyocytes","volume":"32","author":"Feyen","year":"2020","journal-title":"Cell Reports"},{"key":"10.1016\/j.vascn.2024.107530_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241287","article-title":"Specific induction and long-term maintenance of high purity ventricular cardiomyocytes from human induced pluripotent stem cells","volume":"15","author":"Fukushima","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.vascn.2024.107530_bb0070","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1161\/CIRCRESAHA.113.302021","article-title":"Unique metabolic features of stem cells, cardiomyocytes, and their progenitors","volume":"114","author":"Gaspar","year":"2014","journal-title":"Circulation Research"},{"key":"10.1016\/j.vascn.2024.107530_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104756","article-title":"Repolarization studies using human stem cell-derived cardiomyocytes: Validation studies and best practice recommendations","volume":"117","author":"Gintant","year":"2020","journal-title":"Regulatory Toxicology and Pharmacology"},{"key":"10.1016\/j.vascn.2024.107530_bb0080","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.pharmthera.2017.10.001","article-title":"The immature electrophysiological phenotype of iPSC-CMs still hampers in vitro drug screening: Special focus on IK1","volume":"183","author":"Goversen","year":"2018","journal-title":"Pharmacology and Therapeutics"},{"key":"10.1016\/j.vascn.2024.107530_bb0085","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3389\/fphar.2019.00884","article-title":"Considerations for an in vitro, cell-based testing platform for detection of adverse drug-induced inotropic effects in early drug development. Part 1: General considerations for development of novel testing platforms","volume":"10","author":"Guth","year":"2019","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.vascn.2024.107530_bb0090","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1113\/jphysiol.2004.079681","article-title":"Expression pattern of neuronal and skeletal muscle voltage-gated Na+ channels in the developing mouse heart","volume":"564","author":"Haufe","year":"2005","journal-title":"Journal of Physiology"},{"key":"10.1016\/j.vascn.2024.107530_bb0095","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.yjmcc.2014.09.010","article-title":"Image-based evaluation of contraction-relaxation kinetics of human-induced pluripotent stem cell-derived cardiomyocytes: Correlation and complementarity with extracellular electrophysiology","volume":"77","author":"Hayakawa","year":"2014","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"7","key":"10.1016\/j.vascn.2024.107530_bb0100","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/0024-3205(86)90044-5","article-title":"Improvement of the isoprenaline infusion test by plasma concentration measurements","volume":"39","author":"Hjemdahl","year":"1986","journal-title":"Life Sciences"},{"key":"10.1016\/j.vascn.2024.107530_bb0105","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1096\/fj.15-280982","article-title":"Time-dependent evolution of functional vs. remodeling signaling in induced pluripotent stem cell-derived cardiomyocytes and induced maturation with biomechanical stimulation","volume":"30","author":"Jung","year":"2016","journal-title":"FASEB Journal"},{"key":"10.1016\/j.vascn.2024.107530_bb0110","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-1-0716-1484-6_15","article-title":"Assessment of contractility in human iPS cell-derived cardiomyocytes using motion vector analysis","volume":"2320","author":"Kanda","year":"2021","journal-title":"Methods in Molecular Biology"},{"key":"10.1016\/j.vascn.2024.107530_bb0115","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jphs.2018.10.010","article-title":"Development of torsadogenic risk assessment using human induced pluripotent stem cell-derived cardiomyocytes: Japan iPS cardiac safety assessment (JiCSA) update","volume":"138","author":"Kanda","year":"2018","journal-title":"Journal of Pharmacological Sciences"},{"key":"10.1016\/j.vascn.2024.107530_bb0120","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/CIRCRESAHA.117.305990","article-title":"Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction","volume":"117","author":"Khan","year":"2015","journal-title":"Circulation Research"},{"key":"10.1016\/j.vascn.2024.107530_bb0125","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1161\/CIRCRESAHA.113.302095","article-title":"Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes","volume":"113","author":"Kolwicz","year":"2013","journal-title":"Circulation Research"},{"key":"10.1016\/j.vascn.2024.107530_bb0130","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1476-5381.2011.01255.x","article-title":"How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines?","volume":"163","author":"Laverty","year":"2011","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2024.107530_bb0135","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jphs.2017.05.004","article-title":"Overexpression of KCNJ2 in induced pluripotent stem cell-derived cardiomyocytes for the assessment of QT-prolonging drugs","volume":"134","author":"Li","year":"2017","journal-title":"Journal of Pharmacological Sciences"},{"issue":"7","key":"10.1016\/j.vascn.2024.107530_bb0140","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"FeatureCounts: An efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinfomatics"},{"issue":"14","key":"10.1016\/j.vascn.2024.107530_bb0145","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1089\/scd.2012.0490","article-title":"Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells","volume":"22","author":"Lundy","year":"2013","journal-title":"Stem Cells and Development"},{"key":"10.1016\/j.vascn.2024.107530_bb0150","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s12195-015-0413-8","article-title":"Nanopatterned human iPSC-based model of a dystrophin-null cardiomyopathic phenotype","volume":"8","author":"Macadangdang","year":"2015","journal-title":"Cellular and Molecular Bioengineering"},{"key":"10.1016\/j.vascn.2024.107530_bb0155","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/toxsci\/kfx081","article-title":"Blinded contractility analysis in hipsc-cardiomyocytes in engineered heart tissue format: Comparison with human atrial trabeculae","volume":"158","author":"Mannhardt","year":"2017","journal-title":"Toxicological Sciences"},{"issue":"1","key":"10.1016\/j.vascn.2024.107530_bb0160","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2125.1989.tb03509.x","article-title":"Beta-adrenergic receptor responsiveness to isoprenaline in humans: Concentration-effect, as compared with dose-effect evaluation and influence of autonomic reflexes","volume":"28","author":"Martinsson","year":"1989","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.vascn.2024.107530_bb0165","first-page":"E8372","article-title":"Functional screening in human cardiac organoids reveals a metabolic mechanism for cardiomyocyte cell cycle arrest","volume":"114","author":"Mills","year":"2017","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.vascn.2024.107530_bb0170","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nmeth.2524","article-title":"Biowire: A platform for maturation of human pluripotent stem cell-derived cardiomyocytes","volume":"10","author":"Nunes","year":"2013","journal-title":"Nature Methods"},{"key":"10.1016\/j.vascn.2024.107530_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2020.106893","article-title":"Video-based assessment of drug-induced effects on contractile motion properties using human induced pluripotent stem cell-derived cardiomyocytes","volume":"105","author":"Okai","year":"2020","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2024.107530_bb0180","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.stemcr.2016.04.006","article-title":"Isolation and mechanical measurements of myofibrils from human induced pluripotent stem cell-derived cardiomyocytes","volume":"6","author":"Pioner","year":"2016","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.vascn.2024.107530_bb0185","first-page":"569","article-title":"Gene expression of SERCA2a and L-and T-type Ca channels during human heart development","volume":"50","author":"Qu","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.vascn.2024.107530_bb0190","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.biomaterials.2012.11.055","article-title":"The effect of microgrooved culture substrates on calcium cycling of cardiac myocytes derived from human induced pluripotent stem cells","volume":"34","author":"Rao","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.vascn.2024.107530_bb0195","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3389\/fphar.2019.00934","volume":"10","author":"Ribeiro","year":"2019","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"10.1016\/j.vascn.2024.107530_bb0200","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13054-020-02915-5","article-title":"Revisited: Therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics","volume":"24","author":"Schulz","year":"2020","journal-title":"Critical Care"},{"key":"10.1016\/j.vascn.2024.107530_bb0205","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/toxsci\/kfu186","article-title":"An impedance-based cellular assay using human iPSC-derived cardiomyocytes to quantify modulators of cardiac contractility","volume":"142","author":"Scott","year":"2014","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.vascn.2024.107530_bb0210","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1021\/acs.nanolett.9b04152","article-title":"NanoMEA: A tool for high-throughput, electrophysiological phenotyping of patterned excitable cells","volume":"20","author":"Smith","year":"2020","journal-title":"Nano Letters"},{"issue":"9","key":"10.1016\/j.vascn.2024.107530_bb0215","doi-asserted-by":"crossref","first-page":"H1353","DOI":"10.1152\/ajpheart.00705.2013","article-title":"Automated analysis of contractile force and Ca2+ transients in engineered heart tissue","volume":"306","author":"Stoehr","year":"2014","journal-title":"American Journal of Physiology - Heart and Circulatory Physiology"},{"key":"10.1016\/j.vascn.2024.107530_bb0220","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1254\/jjp.66.303","article-title":"Utilization of an isolated, blood-perfused canine papillary muscle preparation as a model to assess efficacy and adversity of class I antiarrhythmic drugs","volume":"66","author":"Sugiyama","year":"1994","journal-title":"The Japanese Journal of Pharmacology"},{"issue":"49","key":"10.1016\/j.vascn.2024.107530_bb0225","first-page":"E4698","article-title":"Design and formulation of functional pluripotent stem cell-derived cardiac microtissues","volume":"110","author":"Thavandiran","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.vascn.2024.107530_bb0230","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.vascn.2013.11.002","article-title":"Low-density plating is sufficient to induce cardiac hypertrophy and electrical remodeling in highly purified human iPS cell-derived cardiomyocytes","volume":"69","author":"Uesugi","year":"2014","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2024.107530_bib286","doi-asserted-by":"crossref","first-page":"105368","DOI":"10.1016\/j.yrtph.2023.105368","article-title":"2000\u20132023 over two decades of ICH S7A: has the time come for a revamp?","volume":"139","author":"Valentin","year":"2023","journal-title":"Regulatory Toxicology and Pharmacology"},{"key":"10.1016\/j.vascn.2024.107530_bb0240","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1128\/AAC.01335-10","article-title":"INX-08189, a phosphoramidate prodrug of 6-O-methyl-2\u2032-C-methyl guanosine, is a potent inhibitor of hepatitis C virus replication with excellent pharmacokinetic and pharmacodynamic properties","volume":"55","author":"Vernachio","year":"2011","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.vascn.2024.107530_bb0245","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jphs.2022.04.010","article-title":"SARS-CoV-2 induces barrier damage and inflammatory responses in the human iPSC-derived intestinal epithelium","volume":"149","author":"Yamada","year":"2022","journal-title":"Journal of Pharmacological Sciences"},{"key":"10.1016\/j.vascn.2024.107530_bb0250","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2131\/jts.46.359","article-title":"Chronic cardiotoxicity assessment of BMS-986094, a guanosine nucleotide analogue, using human iPS cell-derived cardiomyocytes","volume":"46","author":"Yanagida","year":"2021","journal-title":"The Journal of Toxicological Sciences"},{"key":"10.1016\/j.vascn.2024.107530_bb0255","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: A report of the American college of cardiology foundation\/american heart association task force on practice guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.vascn.2024.107530_bb0260","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.stemcr.2022.01.009","article-title":"Deriving waveform parameters from calcium transients in human iPSC-derived cardiomyocytes to predict cardiac activity with machine learning","volume":"17","author":"Yang","year":"2022","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.vascn.2024.107530_bb0265","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1161\/CIRCRESAHA.114.300558","article-title":"Engineering adolescence: Maturation of human pluripotent stem cell-derived cardiomyocytes","volume":"114","author":"Yang","year":"2014","journal-title":"Circulation Research"},{"key":"10.1016\/j.vascn.2024.107530_bb0270","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/toxsci\/kfac095","article-title":"Use of human iPSC-CMs in nonclinical regulatory studies for cardiac safety assessment","volume":"190","author":"Yang","year":"2022","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.vascn.2024.107530_bb0275","first-page":"284","article-title":"clusterProfiler: An R package for comparing biological themes among gene clusters. OMICS","volume":"16","author":"Yu","year":"2012","journal-title":"J. Integrative Biology"},{"key":"10.1016\/j.vascn.2024.107530_bb0280","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1253\/circj.CJ-10-1212","article-title":"Molecular and functional changes in voltage-gated Na+ channels in cardiomyocytes during mouse embryogenesis","volume":"75","author":"Yu","year":"2011","journal-title":"Circulation Journal"},{"key":"10.1016\/j.vascn.2024.107530_bb0285","article-title":"Identification and characterization of calcium sparks in cardiomyocytes derived from human induced pluripotent stem cells","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871924000406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871924000406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:50:49Z","timestamp":1777607449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871924000406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":57,"alternative-id":["S1056871924000406"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2024.107530","relation":{},"ISSN":["1056-8719"],"issn-type":[{"value":"1056-8719","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contractility assessment using aligned human iPSC-derived cardiomyocytes","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2024.107530","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107530"}}